This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Aileron Therapeutics, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Sonoko Kanai: Innovator in Pharmaceutical Formulations
Introduction
Sonoko Kanai is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative treatments for various diseases and disorders.
Latest Patents
Sonoko Kanai holds a patent for "Peptidomimetic macrocycles and formulations thereof." This patent describes aqueous pharmaceutical formulations for parenteral administration that comprise peptidomimetic macrocycles or pharmaceutically acceptable salts. These macrocycles are designed to bind to MDM2 and/or MDMX proteins, providing a novel approach to treating diseases and disorders.
Career Highlights
Throughout her career, Sonoko has demonstrated a commitment to advancing pharmaceutical science. Her work at Aileron Therapeutics, Inc. has positioned her as a key player in the development of cutting-edge therapeutic solutions.
Collaborations
Sonoko collaborates with esteemed colleagues, including David Allen Annis and Krzysztof Darlak, to further enhance the impact of her research and innovations.
Conclusion
Sonoko Kanai's contributions to pharmaceutical formulations exemplify her dedication to improving healthcare through innovative solutions. Her work continues to inspire advancements in the treatment of complex diseases.